Search

everythinglearnresearchcommunity

for

Search:↓

AGA treatments like minoxidil and LLLLT are safe and effective for gender minority patients.

Gender-affirming hormone therapy may increase heart disease risk in transgender individuals.

The girl's unexpected pubic hair growth led to a diagnosis different from complete androgen insensitivity syndrome.

Testosterone therapy seems safe and effective for transgender men with proper care, but more long-term research is needed.

Feminizing hormone therapy increases kidney filtration rate.

A 36-year-old person with a female appearance but male chromosomes was diagnosed with a rare enzyme deficiency affecting sexual development.

Dihydrotestosterone has a reduced effect on muscle-building in people with testicular feminization syndrome, especially after their gonads are removed.

Most 46XX CAH patients have female identity, but a few identify as male and may need treatment and surgery.

Transgender and nonbinary individuals experience hair loss, with transmen on testosterone seeing more severe hair loss, while feminizing hormones may stabilize hair loss in transwomen.

Transgender women can develop feminine traits and improve their quality of life through hormone therapy and surgery, but results vary and access to surgery can be limited.

The treatment helped a transgender woman stop drinking, improved her mental health, and reduced her gender dysphoria.

Personalized hair loss treatments are needed for transgender individuals, but more research is required.

Testosterone pellets might work for transgender men's hormone therapy, but more research is needed.

A 31-year-old woman was diagnosed with Complete Androgen Insensitivity Syndrome much later than usual, leading to a call for earlier detection and treatment guidelines.

Testosterone treatment effectively causes male physical development in transgender male adolescents but may lead to side effects like acne, higher BMI and blood pressure, lower good cholesterol, and decreased bone density.

The review highlights the need for more research on transgender dermatology, the role of dermatologists in gender affirmation, and the effects of hormone therapy on skin and hair.

Future hormone therapy trials should match the diverse needs and priorities of the gender-diverse community.

Gender-affirming hormone treatments need better patient-focused outcome measurements and standardized data collection.

Primary care providers should understand Geschlechtsinkongruenz to offer better care for transitioning individuals.

Most transgender patients getting laser hair removal before gender-affirming surgery are already on hormone therapy, which might affect the hair removal process.

Healthcare providers need better education and resources to give competent and sensitive care to transgender patients.

Following national healthy eating guidelines can help reduce risks from gender-affirming hormone therapy.

In Japan, sex reassignment surgery for gender identity disorder faces challenges and needs better medical support and education.

Gynecologists should provide comprehensive care for transgender patients, including mental health evaluation, hormone therapy, and surgical options, while monitoring for side effects and ensuring patient safety.

Five new mutations in the androgen receptor gene were found, helping to understand androgen insensitivity syndrome better.

Hair restoration helps transgender patients achieve desired gender appearances.

Transgender patients on hormone therapy experience more acne and hair loss, but less skin inflammation.

Some antiandrogens may lower testosterone better than others, but it's unclear which is best for feminization in transgender women; more research is needed.

Dermatopathologists must consider both birth sex and gender identity to accurately diagnose and treat transgender patients.